These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inter-relationship between different platelet measures of 5-HT and their relationship to aggression in human subjects. Marseille R; Lee R; Coccaro EF Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):277-81. PubMed ID: 22019855 [TBL] [Abstract][Full Text] [Related]
25. A relationship between bipolar II disorder and borderline personality disorder? Benazzi F Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1022-9. PubMed ID: 18313825 [TBL] [Abstract][Full Text] [Related]
26. Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites. Mann JJ; Henteleff RA; Lagattuta TF; Perper JA; Li S; Arango V J Neural Transm (Vienna); 1996; 103(11):1337-50. PubMed ID: 9013420 [TBL] [Abstract][Full Text] [Related]
27. The role of affective instability and UPPS impulsivity in borderline personality disorder features. Tragesser SL; Robinson RJ J Pers Disord; 2009 Aug; 23(4):370-83. PubMed ID: 19663657 [TBL] [Abstract][Full Text] [Related]
28. Borderline personality disorder in adolescents: evidence in support of the Childhood Interview for DSM-IV Borderline Personality Disorder in a sample of adolescent inpatients. Sharp C; Ha C; Michonski J; Venta A; Carbone C Compr Psychiatry; 2012 Aug; 53(6):765-74. PubMed ID: 22300904 [TBL] [Abstract][Full Text] [Related]
29. Psychiatric comorbidity in hospitalized adolescents with borderline personality disorder. Ha C; Balderas JC; Zanarini MC; Oldham J; Sharp C J Clin Psychiatry; 2014 May; 75(5):e457-64. PubMed ID: 24922498 [TBL] [Abstract][Full Text] [Related]
30. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients]. Chabrol H; Chouicha K; Montovany A; Callahan S Encephale; 2001; 27(2):120-7. PubMed ID: 11407263 [TBL] [Abstract][Full Text] [Related]
31. Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology. Bruce KR; Steiger H; Ng Ying Kin NM; Israel M Psychiatry Res; 2006 Jun; 142(2-3):225-32. PubMed ID: 16697471 [TBL] [Abstract][Full Text] [Related]
32. Intrafamilial correspondences on platelet [3H-]paroxetine-binding indices in bulimic probands and their unaffected first-degree relatives. Steiger H; Gauvin L; Joober R; Israel M; Ng Ying Kin NM; Bruce KR; Richardson J; Young SN; Hakim J Neuropsychopharmacology; 2006 Aug; 31(8):1785-92. PubMed ID: 16407896 [TBL] [Abstract][Full Text] [Related]
33. Frequency of borderline personality disorder in a sample of French high school students. Chabrol H; Montovany A; Chouicha K; Callahan S; Mullet E Can J Psychiatry; 2001 Nov; 46(9):847-9. PubMed ID: 11761637 [TBL] [Abstract][Full Text] [Related]
34. Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder. Soloff PH; Meltzer CC; Becker C; Greer PJ; Constantine D Psychiatry Res; 2005 Apr; 138(3):183-95. PubMed ID: 15854787 [TBL] [Abstract][Full Text] [Related]
35. The SCID-II and DIB-R interviews: diagnostic association with poor outcome risk factors in Borderline Personality Disorder. Andión Ó; Ferrer M; Di Genova A; Calvo N; Gancedo B; Matalí J; Valero S; Torrubia R; Casas M Psicothema; 2012 Nov; 24(4):523-8. PubMed ID: 23079346 [TBL] [Abstract][Full Text] [Related]
36. A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. Reich DB; Zanarini MC; Bieri KA Int Clin Psychopharmacol; 2009 Sep; 24(5):270-5. PubMed ID: 19636254 [TBL] [Abstract][Full Text] [Related]